欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2354/004
药品名称Paliperidone STADA
活性成分
    • paliperidone palmitate 100.0 mg
剂型Prolonged-release suspension for injection
上市许可持有人STADA Arzneimittel AG Stadastrasse 2-18 61118 Bad Vilbel Germany
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Germany (DE)
    • Greece (GR)
    • Denmark (DK)
    • Norway (NO)
    • Belgium (BE)
      Paliperidon EG 100 mg suspensie voor injectie met verlengde afgifte in een voorgevulde spuit
    • Finland (FI)
    • Netherlands (NL)
    • Hungary (HU)
      Paliperidone Palmitate Stada 100 mg retard szuszenziós injekció
    • Luxembourg (LU)
    • Cyprus (CY)
      Paliperidone palmitate/STADA 100mg prolonged-release suspension for injection
    • Iceland (IS)
    • Romania (RO)
    • Ireland (IE)
    • Slovakia (SK)
    • Austria (AT)
    • Malta (MT)
      Paliperidone Clonmel Prolonged-Release Suspension for Injection 100mg
    • France (FR)
许可日期2024/03/14
最近更新日期2024/04/25
药物ATC编码
    • N05AX13 paliperidone
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase